There are reports on trends in prescriptions for GLP-1 receptor agonists, with various time frames cited, including January 2018 to March 2025, January 2018 to September 2025, and January 2019 to March 2026. The topic appears to be related to broader discussions on prescription drugs, their prices, and healthcare trends. The specific details and implications of these trends are not clearly defined, with multiple outlets and sources weighing in on the issue.